Mackay Shields LLC’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,200
Closed -$1.18M 1612
2020
Q1
$1.18M Sell
8,200
-400
-5% -$57.8K 0.01% 889
2019
Q4
$1.76M Buy
+8,600
New +$1.76M 0.01% 922